Spiriva HandiHaler 18mg Boehringer Ingelheim
€40.00
Description
Understanding Spiriva HandiHaler 18mg
Spiriva HandiHaler 18mg, developed by Boehringer Ingelheim, is renowned for its efficacy in managing chronic obstructive pulmonary disease (COPD) and asthma symptoms. The primary active ingredient, tiotropium bromide, belongs to the class of medications known as long-acting anticholinergics. By targeting specific receptors in the airways, Spiriva facilitates an open passage for airflow, enhancing respiratory function.
Physiological Role of Tiotropium Bromide
Tiotropium primarily works by blocking acetylcholine receptors in the smooth muscle of the bronchi. This inhibition leads to bronchodilation, which decreases airway resistance and improves lung capacity. While Spiriva is not directly linked to muscle growth, its ability to enhance oxygen delivery during exercise can indirectly support athletic performance. Improved lung function contributes to greater endurance and recovery, allowing athletes to train more effectively and achieve their fitness goals.
Influence on Recovery and Performance
With enhanced respiratory efficiency, athletes often report improved recovery rates post-exercise. The oxygen delivered can expedite muscle repair processes and metabolic regulation, which are crucial for those engaged in physically demanding activities. Clinical studies suggest that improved oxygenation through effective inhalation therapies can help optimize energy production in muscles, directly impacting muscle hypertrophy and overall workout performance.
Metabolic Regulation and Testosterone Support
Although Spiriva HandiHaler is not categorized as an anabolic steroid, its role in enhancing oxygen availability may influence metabolic regulation positively. Sufficient oxygenation supports increased energy levels and endurance, indirectly fostering an environment conducive to muscle anabolism. Some fitness enthusiasts observe that improved aerobic capacity and efficient recovery can create an optimal scenario for natural testosterone support, allowing for better hormonal balance during intense training cycles.
Dosage and Usage Guidelines
Typically, Spiriva HandiHaler is administered at a standard dosage of 18 micrograms once daily. This regimen is straightforward yet effective, making it suitable for both beginners and intermediate users aiming to enhance their respiratory capabilities. It is crucial, however, to adhere strictly to prescribed dosages to maximize benefits and minimize risks. Consulting with a healthcare professional before initiating use can provide customized insights based on individual health profiles.
Responsible Usage and Side-Effect Awareness
As with any medication, awareness of potential side effects is essential. While Spiriva is generally well-tolerated, some users may experience mild adverse effects such as dry mouth or constipation. Monitoring one’s response to the medication and reporting any concerns to a healthcare provider ensures safe usage. The production of Spiriva adheres to stringent quality control standards, reflecting Boehringer Ingelheim’s commitment to safety and efficacy.
Maximizing Performance Safely
For those ready to take their performance to the next level, Spiriva HandiHaler 18mg stands as a scientifically backed option. With proper guidance and responsible usage, athletes can optimize their training sessions and overall health. If you’re ready to maximize your performance safely, this is your next step.
Additional information
| Raw Material | Tiotropium Bromide |
|---|---|
| Water Retention | No |
| Hepatotoxicity | No known hepatotoxic effects |
| Lab Test | Not typically affected by standard lab tests |
| Also known as | Tiotropium |
| Blood pressure | Little or no effect on blood pressure |
| Trade name | Spiriva |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | Tiotropium bromide |
| Formula | C19H22BrNO4S2 |
| Substance class | Anticholinergic bronchodilator |
| Main action | Inhibits acetylcholine's action on bronchial smooth muscle leading to bronchodilation |
| Half-life | 5 to 6 days |
| Dosage (medical) | 18 micrograms once daily via inhalation |
| Dosage (sports) | Not applicable |
| Effects | Promotes bronchodilation, reduces bronchospasm |
| Side effects | Dry mouth, cough, sinusitis, upper respiratory tract infection, constipation, urinary retention |
| Use in sports | None |
| Manufacturer | BOEHRINGER INGELHEIM |
| Packing | 30 caps (18 mg) |




Reviews
There are no reviews yet.